Heartflow, Inc. stocks have been trading up by 9.63 percent following highly positive sentiment from its most impactful cardiovascular imaging breakthrough news.
Click Here for a Millionaire's POV on Trading HTFL
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
What Traders Need To Know
- Shares ripped higher, surging as much as 33% after Heartflow, Inc. posted a narrower Q2 non-GAAP loss and stronger revenue.
- Momentum followed repeated headlines noting higher revenue and an upgraded 2026 revenue outlook, fueling bullish sentiment around HTFL.
- Earnings showed a narrower-than-expected Q2 loss with revenue growth, helping explain the sharp re-rating in Heartflow, Inc. stock.
- Price action and guidance now put HTFL firmly on the radar of short-term momentum and swing traders.
Weekly Update Sep 07 – Sep 11, 2026: On Sunday, September 13, 2026 Heartflow, Inc. stock [NASDAQ: HTFL] is trending up by 9.63%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Healthcare industry expert:
Analyst sentiment – positive
HeartFlow (HTFL) sits in an attractive, high‑margin cardiology diagnostics niche with 80% gross margin but remains structurally unprofitable, with EBIT margin around –54% and ROIC worse than –50%. Revenue of ~$176M on an enterprise value of ~$4.2B embeds a rich multiple despite negative free cash flow (–$10.5M last quarter) and heavy opex (R&D plus SG&A >$97M annualized run‑rate). Balance sheet quality is strong: minimal leverage (total debt/equity ~0.1), ample liquidity (current ratio ~5.1, cash and ST investments ~$163M).
Technically, HTFL is in a short‑term uptrend after a sharp post‑earnings repricing: the weekly sequence from ~45 to ~50 shows higher lows and strong demand absorption near 45–46, with the latest close at 49.87 printing near the weekly high. Intraday 5‑minute candles show active dip‑buying on volume spikes every time price approaches the mid‑40s. A clear actionable level is support at 45; sustained trading above 50 on rising volume opens a momentum extension toward the mid‑50s.
More Breaking News
- Why Did BCAT Break Its Normal Speed?
- VSME Stock Jumps As VS Media Holdings Draws Trader Attention
- How Rare Was UTF’s After-Hours Move?
- How Rare Was NWSA’s Sudden Move?
Recent news flow is distinctly favorable: multiple reports of a narrower Q2 loss, higher revenue, and a raised 2026 outlook have driven a 24–33% share price surge and reset expectations versus Healthcare and Providers & Services peers, where growth and margins are generally less explosive but more balanced. HTFL now trades as a high‑growth, high‑risk asset. Base case: accumulate on pullbacks toward 45–46, initial support 45, near‑term resistance 52–54, 12‑month upside target 60.
Quick Financial Overview
Heartflow, Inc. is still losing money, but the direction of travel is improving, and that is what the market is trading. Q2 revenue was about $176.0M on a trailing basis, while the latest quarter showed $64.1M in total revenue and $53.2M in gross profit. An 80.1% gross margin is strong for a high-growth medical technology name, even though the company posted a Q2 net loss of $15.7M and an EBITDA loss of $13.5M.
Profitability ratios confirm Heartflow, Inc. is deep in the red, with profit margins around -55% and very weak returns on assets and equity. The key offset is balance-sheet strength: cash, cash equivalents, and short-term investments total $162.6M, current assets stand at $224.0M, and current liabilities are only $44.1M. A current ratio above 5 and low debt levels (total liabilities of $64.7M versus equity of $279.7M) give HTFL room to fund losses while it scales.
On the chart, HTFL just had a classic earnings breakout. Weekly data show the stock trading around the mid‑$40s, then spiking to the $49–$50 zone, matching intraday action where price ran from the low‑$46s to above $50 before settling near $49.9. That type of wide intraday range after news, with a strong close near the high, is textbook confirmation that traders are chasing the raised 2026 revenue outlook and the narrower Q2 loss.
Conclusion
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.